Preclinical Models Used for Immunogenicity Prediction of Therapeutic Proteins
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Models Used for Immunogenicity Prediction of Therapeutic Proteins
Authors
Keywords
immunogenicity, predictive models, therapeutic proteins
Journal
PHARMACEUTICAL RESEARCH
Volume 30, Issue 7, Pages 1719-1728
Publisher
Springer Nature
Online
2013-05-07
DOI
10.1007/s11095-013-1062-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD
- (2012) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Immunogenicity of Therapeutic Proteins: The Use of Animal Models
- (2011) Vera Brinks et al. PHARMACEUTICAL RESEARCH
- Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
- (2011) Miranda M. C. van Beers et al. PHARMACEUTICAL RESEARCH
- Prediction of Immunogenicity of Therapeutic Proteins
- (2010) Christine J. Bryson et al. BIODRUGS
- Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics
- (2010) Danika Wullner et al. CLINICAL IMMUNOLOGY
- Immunological substance testing on human lymphatic micro-organoids in vitro
- (2010) Christoph Giese et al. JOURNAL OF BIOTECHNOLOGY
- Have we overestimated the benefit of human(ized) antibodies?
- (2010) Daniel R. Getts et al. mAbs
- Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
- (2009) M K de Vries et al. ANNALS OF THE RHEUMATIC DISEASES
- Can we prevent immunogenicity of human protein drugs?
- (2009) D W Scott et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study
- (2009) G. M. Bartelds et al. ANNALS OF THE RHEUMATIC DISEASES
- The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γcnull (NOG) mice (hu-HSC NOG mice)
- (2009) Yohei Watanabe et al. INTERNATIONAL IMMUNOLOGY
- Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta
- (2009) Miranda M.C. van Beers et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A
- (2009) S. MADOIWA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule
- (2009) Varsha V. Kapoerchan et al. MOLECULAR IMMUNOLOGY
- Immunological mechanism underlying the immune response to recombinant human protein therapeutics
- (2009) Melody Sauerborn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
- (2008) A DEGROOT et al. CURRENT OPINION IN PHARMACOLOGY
- Epoetin-associated pure red cell aplasia: past, present, and future considerations
- (2008) June M. McKoy et al. TRANSFUSION
- New Approaches to Prediction of Immune Responses to Therapeutic Proteins during Preclinical Development
- (2008) Laura C A Perry et al. Drugs in research & development
- Benchmarking B cell epitope prediction: Underperformance of existing methods
- (2004) Martin J. Blythe et al. PROTEIN SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started